Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.neuropsych.12020044DOI Listing

Publication Analysis

Top Keywords

paliperidone monotherapeutic
4
monotherapeutic agent
4
agent schizophrenic
4
schizophrenic patient
4
patient cirrhosis
4
cirrhosis liver
4
paliperidone
1
agent
1
schizophrenic
1
patient
1

Similar Publications

Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.

J Clin Psychopharmacol

August 2015

From the *Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; †Independent Consultant, Boston, MA; ‡Alkermes, Inc, Waltham, MA; and §University of Pennsylvania, School of Social Policy & Practice, Philadelphia, PA.

Pharmacological treatment is central to effective management of schizophrenia. Prescribing clinicians have an increasing array of options from which to choose, and oral antipsychotic polypharmacy is common in routine clinical practice. Practice guidelines recommend long-acting injectable (LAI) formulations, typically viewed as monotherapeutic alternatives, for patients with established nonadherence.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!